Editor's letter

Issue 78 • September 2024

Don’t miss out – sign up to our free industry-leading magazine and newsletters

Follow us on Twitter

Welcome to the latest issue of the Medical Technology magazine

In this month’s edition of Medical Technology, we look at the remote monitoring technologies emerging to meet the needs of patients with chronic conditions.

According to GlobalData’s Market Size and Growth database, the overall patient monitoring market was valued at around $18bn in 2023 and is forecast to reach a valuation of almost $24bn by 2033. The indication-specific mobile apps segment of the digital health market was valued at around $2.1m in 2023 and is projected to reach a valuation of around $10.7m by 2033.

We also explore how artificial intelligence is being used to personalise IVF treatment.  Research shows that AI has the potential to influence the optimisation and personalisation of key steps in IVF, including cycle monitoring, induction of oocyte (egg) maturation, and selection of the most competent gametes and embryos, to improve the overall efficacy and safety of ART.

All this and the latest medical device industry news, comment, and analysis from GlobalData.  

Catherine Longworth, editor

Go to article: Home | Remote patient monitoring across chronic conditionsGo to article: Editor's letterGo to article: ContentsGo to article: Bellridge Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Alleima Company InsightGo to article: AlleimaGo to article: In DepthGo to article: Remote patient monitoring across chronic conditions Go to article: IVF: AI ushers new paradigm for fertility medicine Go to article: Family offices branching out to become ideal source for early MedTech funding Go to article: Explainer: Why paediatric healthcare is furious with the FDA’s LDT final ruling Go to article: A thorn in TGA’s side – spinal cord stimulators under fire in Australia Go to article: Repsol Company InsightGo to article: Repsol Go to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Next issue